Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

NCT06082063 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Heart Failure
Type 1 Diabetes
Kidney Failure

Interventions

DRUG: Aspirin tablet
DRUG: Semaglutide
DRUG: Sotagliflozin
DRUG: Finerenone

Sponsor

Steno Diabetes Center Copenhagen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]